US Broker Ratings

COMPASS Pathways Plc (CMPS): Analyst Ratings Suggest 327% Upside Potential in Mental Health Breakthroughs

For investors seeking opportunities in the healthcare sector, COMPASS Pathways Plc (NASDAQ: CMPS) presents an intriguing case. As a pioneering biotechnology firm focused on mental health,..

Nuvation Bio Inc. (NUVB) Stock Analysis: Exploring a 210% Potential Upside in the Biotech Sector

Nuvation Bio Inc. (NASDAQ: NUVB) stands out in the competitive biotech sector with a compelling story for investors seeking high-growth potential. As a clinical-stage biopharmaceutical company,..

Inventiva S.A. – American Depos (IVA) Stock Analysis: Unveiling a 222% Potential Upside in the Biotechnology Sector

Inventiva S.A. – American Depos (IVA) is a promising player in the biotechnology industry, attracting attention from investors seeking substantial growth in their portfolios. Headquartered in..

Tourmaline Bio, Inc. (TRML) Investor Outlook: Exploring a 220% Potential Upside in the Biotech Sector

Tourmaline Bio, Inc. (NASDAQ: TRML), a promising player in the biotechnology sector, is catching the attention of investors with its substantial potential upside. With a market..

Bicycle Therapeutics plc (BCYC) Stock Analysis: Unveiling a 224.76% Potential Upside in the Biotech Arena

Bicycle Therapeutics plc (NASDAQ: BCYC), a pioneering entity in the biotechnology sector, presents a compelling opportunity for investors seeking substantial growth in the healthcare industry. With..

Syndax Pharmaceuticals (SNDX) Stock Analysis: Exploring a 248% Potential Upside in Biotechnology

Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX) is capturing the attention of investors with a compelling potential upside of 248%. As a commercial-stage biopharmaceutical company, Syndax focuses on..

Cross Country Healthcare, Inc. (CCRN) Stock Analysis: Exploring a 45% Potential Upside

Cross Country Healthcare, Inc. (NASDAQ: CCRN) is making waves in the healthcare industry, specifically within the medical care facilities sector. With a market capitalization of $404.63..

Butterfly Network, Inc. (BFLY) Stock Analysis: Unveiling a 122.82% Potential Upside in Medical Device Innovation

Butterfly Network, Inc. (NASDAQ: BFLY) has been gaining traction in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $443.46 million,..

Surmodics, Inc. (SRDX) Investor Outlook: Navigating Challenges in the Medical Devices Sector

Surmodics, Inc. (NASDAQ: SRDX), a key player in the healthcare sector, is renowned for its innovative contributions to the medical devices industry. With a market capitalization..

Sage Therapeutics, Inc. (SAGE): Investor Outlook and Ratings Reveal Limited Upside Potential

Investors navigating the dynamic field of biotechnology would do well to keep an eye on Sage Therapeutics, Inc. (NASDAQ: SAGE), a company specialized in brain health..

Owens & Minor, Inc. (OMI) Stock Analysis: Navigating Challenges with a Promising 14.73% Upside

Owens & Minor, Inc. (NYSE: OMI), a key player in the healthcare sector, particularly within the medical distribution industry, offers a blend of opportunities and challenges..

Celcuity Inc. (CELC) Stock Analysis: A 110% Upside Potential in Biotechnology

For investors with a keen eye on the healthcare sector, particularly biotechnology, Celcuity Inc. (NASDAQ: CELC) represents a compelling opportunity. The Minnesota-based clinical-stage biotech company is..

Maze Therapeutics, Inc. (MAZE) Stock Analysis: Unlocking a 59.85% Potential Upside in Biotechnology

For biotechnology investors seeking promising opportunities in the healthcare sector, Maze Therapeutics, Inc. (NASDAQ: MAZE) presents an intriguing proposition with a notable potential upside of 59.85%...

Ginkgo Bioworks Holdings, Inc. (DNA) Stock Analysis: Navigating Volatility in the Biotech Sector

Ginkgo Bioworks Holdings, Inc. (NASDAQ: DNA) is a compelling entity in the biotechnology industry, offering a unique proposition with its cell engineering and biosecurity solutions. As..

MeiraGTx Holdings plc (MGTX) Stock Analysis: A Biotech Gem with 219% Potential Upside

MeiraGTx Holdings plc (NASDAQ: MGTX) has emerged as a captivating player in the biotechnology sector, capturing the attention of investors with its promising pipeline of gene..

Sana Biotechnology, Inc. (SANA) Stock Analysis: Exploring a Potential 129.88% Upside in the Biotech Sector

Sana Biotechnology, Inc. (NASDAQ: SANA) is making waves in the biotechnology sector, with a market capitalization of $918.01 million. As a company focused on the innovative..

EyePoint Pharmaceuticals, Inc. (EYPT): A Biotechnology Stock with a Compelling 186% Upside Potential

EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a promising player in the biotechnology sector, is capturing the attention of investors with its robust pipeline and a striking potential..

Theravance Biopharma, Inc. (TBPH) Stock Analysis: Exploring a 50% Potential Upside

Theravance Biopharma, Inc. (NASDAQ: TBPH), a dynamic player in the biotechnology sector, has been garnering attention from investors seeking substantial growth potential in the healthcare industry...

Opthea Limited (OPT) Stock Analysis: Healthcare Innovator Faces a Critical Phase Amid -60.90% Potential Downside

Investors with a keen interest in biotechnology and healthcare are no strangers to the speculative nature of investing in clinical-stage biopharmaceutical companies. Opthea Limited (NASDAQ: OPT),..

Cel-Sci Corporation (CVM): Analyzing the 6,183% Upside Potential in Biotechnology

For investors with an appetite for high-risk, high-reward opportunities, Cel-Sci Corporation (NASDAQ: CVM) presents a compelling case. Operating within the healthcare sector and more specifically, the..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds